PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns. Have an internal positioning decision? The private Sprint uses a separate evidence boundary.

See the private Research Sprint →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago7943 SIGNALS8 FEEDS580 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
1241 Opportunity dossier O-1425 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1242 Opportunity dossier O-1385 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1243 Opportunity dossier O-1383 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1244 Opportunity dossier O-1365 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1245 Opportunity dossier O-1342 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1246 Opportunity dossier O-1337 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1247 Opportunity dossier O-1046 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1248 Opportunity dossier O-1045 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1249 Opportunity dossier O-1014 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1250 Opportunity dossier O-1011 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1251 Opportunity dossier O-0988 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1252 Opportunity dossier O-0969 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1253 Opportunity dossier O-0968 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1254 Opportunity dossier O-0967 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1255 Opportunity dossier O-0964 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1256 Opportunity dossier O-0923 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1257 Opportunity dossier O-0917 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1258 Opportunity dossier O-0905 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1259 Opportunity dossier O-0893 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1260 Opportunity dossier O-0888 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.